SEC Form 4 · accession 0001274225-18-000009
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2018 | M | 30,000 | $24.40 | A | 69,743 | D | |
| Common Stock | Jun 1, 2018 | S | 30,000 | $38.90 | D | 39,743 | D | |
| Common Stock | Jun 4, 2018 | M | 10,000 | $24.39 | A | 49,743 | D | |
| Common Stock | Jun 4, 2018 | S | 10,000 | $39.90 | D | 39,743 | D | |
| Common Stock | Jun 4, 2018 | M | 8,404 | $21.29 | A | 48,147 | D | |
| Common Stock | Jun 4, 2018 | S | 8,404 | $39.90 | D | 39,743 | D | |
| Common Stock | Jun 5, 2018 | M | 1,227 | $21.29 | A | 40,970 | D | |
| Common Stock | Jun 5, 2018 | S | 1,227 | $39.90 | D | 39,743 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $21.29 | Jun 4, 2018 | M | 8,404 | D | Dec 2, 2012 | Dec 2, 2021 | Common Stock | 8,404 | 21,596 | D |
| Non-Qualified Stock Option (right to buy) | $21.29 | Jun 5, 2018 | M | 1,227 | D | Dec 2, 2012 | Dec 2, 2021 | Common Stock | 1,227 | 20,369 | D |
| Non-Qualified Stock Option (right to buy) | $24.39 | Jun 4, 2018 | M | 10,000 | D | Jul 1, 2009 | Nov 13, 2018 | Common Stock | 10,000 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $24.40 | Jun 1, 2018 | M | 30,000 | D | Nov 5, 2010 | Nov 5, 2019 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.